Infections and Atheromatous Plaque: Current Therapeutic Implications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|9|1638-1650

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.9, 2013-03, pp. : 1638-1650

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarkers Associated with Vulnerable Atheromatous Plaque

By  

Current Medicinal Chemistry, Vol. 19, Iss. 16, 2012-06 ,pp. : 2588-2596

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinases and Vulnerable Atheromatous Plaque

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-05 ,pp. : 1166-1180

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Delivery Strategies Targeting Stable Atheromatous Plaque

By  

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1626-1637

Bentham Science Publishers

Access to resources Recommend Favorite

Immune Responses to Fungal Infections and Therapeutic Implications

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 1, Iss. 3, 2001-11 ,pp. : 189-197

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of microRNAs in the Initiation and Progression of Stable Atheromatous Plaque

By  

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1651-1657

Bentham Science Publishers

Access to resources Recommend Favorite